News

Results of a large Phase 3 clinical trial reveal that a targeted cancer drug, osimertinib, cut the risk of death by 51% for patients following surgery to remove non-small cell lung cancers harboring a specific mutation.

The U.S. biosimilar drug market emerged in 2015 to provide safe, effective and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.

It has been unclear how the microbiome responds to repeated antibiotic therapy, but a preclinical study, using metagenome and cultivation analyses, has identified evolutionary mechanisms that contribute to the resilience of the microbial community.

Scientists have found that a peptide from fruit flies could lead to new antibiotics.

Researchers have revealed the structure and function of a drug which can reduce the harmful activity of the immune system to help treat autoimmune diseases, and is currently in a Phase 2 clinical trial for lupus.

Researchers have found that for menopausal women, continuously wearing a nitroglycerin patch provided short-term improvements in moderate to severe hot flashes but the benefits did not extend past 12 weeks.

Tirzepatide is a recently approved treatment for type-2 diabetes. Treatment with tirzepatide decreases body weight while improving glucose metabolism in patients with obesity and type-2 diabetes.

A new study has revealed details about how the psychedelic drugs LSD and psilocin – the active ingredient in magic mushrooms – bind to receptors in the brain.

In the phase 3 INDIGO clinical trial, vorasidenib significantly prolonged progression free survival and delayed radiation and chemotherapy for patients with Grade 2 IDH-mutant glioma.

Two new discoveries highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.